News | EP Mapping and Imaging Systems | August 17, 2020

Northwestern Medicine One of First to Use Dielectric Imaging System to Guide Cardiac Ablation

System reduces radiation exposure, provides 3-D, high-definition images of heart in real time

August 17, 2020 — A Northwestern Medicine Bluhm Cardiovascular Institute physician was the first electrophyiologist in Illinois to use a new advanced imaging system during cryo-ablation for atrial fibrillation. 

The Philips’ Kodex-EPD system uses dielectric imaging to creates 3-D, high-definition images of a patient’s cardiac structures in real time. A completely new approach to imaging the heart, dielectric imaging offers many benefits in comparison to current approaches, for both cryo and radiofrequency ablation procedures. The technology provides real-time 3-D imaging, reducing the need for X-ray imaging and radiation exposure.

Bradley Knight, M.D., medical director of cardiac electrophysiology at Northwestern Memorial Hospital, was one of the first in the country to use the Phillips Kodex-EPD system. The system offered 3-D, high-definition images of a patient’s heart, during an atrial fibrillation (AFib) ablation procedure Aug. 5, 2020.

“I was impressed that this completely new three-dimensional mapping system, which acts much like a GPS system, can accurately and quickly re-create the anatomy of the cardiac chamber of interest and display the heart’s electrical activity using any electrode pairs placed in the heart,” Knight said.

In cryoablation, imaging is critical to help the physician guide the catheter. 

“As the population ages more Americans are being diagnosed with AFib,” said Knight, who is also the Chester C. and Deborah M. Cooley Distinguished Professor of Cardiology at Northwestern University Feinberg School of Medicine. “We are always looking for the safest, most advanced treatments for our heart rhythm patients and I was pleased to partner on this new technology.”

The Kodex-EDP system has both FDA 510(k) clearance and European CE mark.

Northwestern Medicine’s Bluhm Cardiovascular Institute is one of the top 10 national programs for cardiology and heart surgery, according to U.S. News and World Report, and ranked the top cardiovascular program in Illinois and the surrounding states for more than 10 consecutive years. 

More than 6 million Americans may have AFib, a heart rhythm disorder when the upper and lower chambers of the heart beat out of synch, either too slowly, too quickly or simply irregularly. Symptoms can include heart palpitations, extreme fatigue, chest pain or shortness of breath, though some with AFib experience no symptoms.

A major risk of AFib is stroke, and one in seven strokes is attributed to AFib.

For more information: news.nm.org/about-northwestern-medicine.html

 

Related Kodex-EPD Dielectric Imaging System Content:

4 Key Takeaways From the 2019 Heart Rhythm Society Meeting

Philips and Medtronic Collaborate on Image-guided Atrial Fibrillation Treatment
 

Related Content

ECG with paroxysm correct form of atrial flutter. Getty Images

ECG with paroxysm correct form of atrial flutter. Getty Images

News | Atrial Fibrillation | December 23, 2020
December 23, 2020 — The American College of Cardiology (ACC) and the American Heart Association (AHA) has made two up
The three-year clinical outcomes of the mHealth Screening to Prevent Strokes (mSToPS) study evaluated the detection of silent, or previously undiagnosed, atrial fibrillation (AF) in moderate-risk individuals using the FDA-cleared Zio by iRhythm ambulatory monitoring patch. The results support the clinical value of early screening and targeted detection in moderate-risk populations. #AHA #AHA20 #AHA2020

The three-year clinical outcomes of the mHealth Screening to Prevent Strokes (mSToPS) study evaluated the detection of silent, or previously undiagnosed, atrial fibrillation (AF) in moderate-risk individuals using the FDA-cleared Zio by iRhythm ambulatory monitoring patch. The results support the clinical value of early screening and targeted detection in moderate-risk populations.

News | Atrial Fibrillation | November 16, 2020
November 16, 2020 — The three-year clinical outcomes of the mHealth Screening to Prevent Strokes (mSToPS) study evalu
The Medtronic SEEQ mobile cardiac telemetry system, pictured here, and the Icentia CardioSTAT cardiac rhythm monitoring device both found in reased rates of post-operative atrial fibrillation in the SEARCH-AF trial presented at the American Heart Association annual meeting. #AHA #AHA20 #AHA2020

The Medtronic SEEQ mobile cardiac telemetry system, pictured here, and the Icentia CardioSTAT cardiac rhythm monitoring device both found in reased rates of post-operative atrial fibrillation in the SEARCH-AF trial presented at the American Heart Association annual meeting.

News | Atrial Fibrillation | November 16, 2020
November 16, 2020 — Atrial fibrill...
The Medtronic Arctic Front cryoballoon balloon was used a a front-line treatment of AF in the EARLY-AF trial. It was found to be better than anti-arrhythmic drugs in preventing the recurrence of abnormal heart rhythm (atrial tachyarrhythmia, atrial fibrillation), and improve patient well-being.  #AHA #AHA2020 #AHA20

The Medtronic Arctic Front cryoballoon balloon was used a a front-line treatment of AF in the EARLY-AF trial. It was found to be better than anti-arrhythmic drugs in preventing the recurrence of abnormal heart rhythm (atrial tachyarrhythmia, atrial fibrillation), and improve patient well-being.  

News | Atrial Fibrillation | November 16, 2020
November 16, 2020 – Doctors from the Mo...

The study used cadaver hearts that were images with contrast enhanced MRI and the images used to create a 3-D computation model of the electrical activation in the heart and how it was influenced by adenosine and ablation. Find more images in the original article

News | Atrial Fibrillation | October 08, 2020
October 8, 2020 – People who suffer from persistent atrial fibrillation in the heart may find relief from a new treat
The TactiFlex PAF investigational device exemption (IDE) study will evaluate he investigational TactiFlex Ablation Catheter, Sensor Enabled (SE) to treat people suffering from paroxysmal atrial fibrillation (PAF). 

The TactiFlex PAF investigational device exemption (IDE) study will evaluate he investigational TactiFlex Ablation Catheter, Sensor Enabled (SE) to treat people suffering from paroxysmal atrial fibrillation (PAF). 

News | Atrial Fibrillation | August 04, 2020
August 4, 2020 — Abbott announced the first enrollments in the TactiFlex PAF  investigational device exemption (IDE)
PREDICT-AF trial showed first time there is extensive extracellular matrix remodeling. #HRS2020 #Heartrhythm2020. Marilyn Fornell
News | Atrial Fibrillation | May 19, 2020
May 19, 2020 — Structural changes of the atrium may occur long before the onset of atrial fibrillation (AF), and the